On June 1, 2016, AbbVie Inc. (“AbbVie”) entered into an accelerated share repurchase agreement (the “agreement”) with JPMorganChase (“JPMorgan”) to repurchase $3.8 billion (the “prepayment amount”) of AbbVie’s common stock. …
NEW YORK, Jan. 24, 2018--. In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of ...
NEW YORK, Jan. 24, 2018--. In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of ...